Tag: Johnson & Johnson

Johnson & Johnson Shells Out Nearly $9 Billion to Settle Cancer Allegations

Admin

Johnson & Johnson agreed to dole out $8.9 billion to numerous people who alleged the pharmaceutical giant’s talcum powder products led to cancer on Tuesday, according to a proposal released in filing Tuesday.

The plaintiffs include the relatives of people who perished from ovarian cancer and mesothelioma allegedly due to Johnson & Johnson products; if the settlement is approved, it will put an end to their long legal saga, according to The New York Times. Under Johnson & Johnson’s proposed settlement, the giant would pay the nearly $9 billion over the next 25 years to the plaintiffs.

Read the full story

Michigan to Begin $81 Million Opioid Settlement Distribution

The Center Square

Michigan’s government is expected to receive part of $81 million from two multi-state opioid settlements later this month.

“I am relieved the court ruled in accordance with the law, and I thank the judge for the keen attention she paid to this important matter,” Michigan Attorney General Dana Nessel said in a statement. “It’s critical that communities throughout Michigan are indemnified for the harm they suffered due to the recklessness of the opioid manufacturers and distributors. The frivolous challenge by Ottawa County delayed millions of dollars from being put to good use to help Michigan residents our communities recover.”

Read the full story

Georgia Joins Walmart Opioid Settlement

Eric Burk

The state of Georgia has signed on to a $3.1 billion national agreement with Walmart amid allegations that the retailer didn’t properly monitor opioids dispensing at its pharmacies; Georgia is expected to get $28 million in the deal, according to an announcement from Attorney General Chris Carr.

“The opioid epidemic has destroyed lives, families, and communities all across our state and nation,” Carr said in the release.

Read the full story

Virginia Expects $60 Million in Tentative Opioid Crisis Settlement with Walmart

Eric Burk

Virginia is expected to receive $60 million as part of a tentative $3.1 billion settlement agreement with Walmart after allegations of insufficient oversight of opioid dispensing at the chain’s pharmacies.

“Companies who facilitated the dispensing of opioids contributed to the opioid epidemic that has devastated millions of lives. This significant settlement will help us fight back against the epidemic and provide abatement and rehabilitation resources to suffering Virginians,” Attorney General Jason Miyares said in a press release.

Read the full story

Ohio Attorney General Announces Preliminary Agreement with Walmart on Opioid Addiction Liability

Bradley Vasoli

Ohio Attorney General Dave Yost (R) announced on Tuesday that he and 15 other state attorneys general have negotiated a preliminary deal with the multinational retailer Walmart, from which Ohio would get $114 million for opioid recovery programs.

The $3.1 billion national agreement comes after Yost and other prosecutors sought accountability for what they characterize as the superstore’s failure to safely and securely dispense high-strength prescription pain relievers through its more than 5,100 pharmacies across America. Other state prosecutor’s offices who worked alongside him include California, Colorado, Connecticut, Delaware, Illinois, Indiana, Iowa, Louisiana, Massachusetts, North Carolina, Nebraska, Pennsylvania, New York, Tennessee and Texas.
The agreement comes after Yost and other prosecutors sought accountability for what they characterize as the superstore’s failure to safely and securely dispense high-strength prescription pain relievers through its more than 5,100 pharmacies across America. Other state prosecutor’s offices who worked alongside him include California, Colorado, Connecticut, Delaware, Illinois, Indiana, Iowa, Louisiana, Massachusetts, North Carolina, Nebraska, Pennsylvania, New York, Tennessee and Texas.

Read the full story

Pennsylvania Counties Take the Lead in Spending Opioid Settlement Dollars

The Center Square

Pennsylvania is set to spend $1 billion from the National Opioid Settlement – and the focus is on the county level.

Pennsylvania’s share of the $26 billion settlement will be divvied up so that 70% goes to counties, 15% is appropriated by the General Assembly, and 15% goes to counties involved in the opioid litigation, subdivisions, district attorneys, and special districts.

Read the full story

Mark Brnovich Announces Two Multistate Settlements with Four Pharmaceutical Companies for Their Roles in the Opioid Crisis

Neil Jones

Arizona Attorney General Mark Brnovich (R) recently announced two historic multistate settlements, totaling $26 billion, with four pharmaceutical companies over their roles in the opioid crisis.

“We are working to get these opioid abatement funds to local communities as quickly as possible,” Brnovich said in a press release. “They will help facilitate more effective treatment, education, and prevention as our state continues to tackle this heartbreaking crisis.”

Read the full story

Georgia Could Receive $636 Million as Part of Opioid Settlement

The Center Square

Georgia Gov. Brian Kemp signed a measure that opens the door to $636 million for state and local governments to bolster their opioid treatment and prevention efforts.

The money is part of a $26 billion multistate opioid settlement with the nation’s three major pharmaceutical distributors — Cardinal, McKesson and AmerisourceBergen — and opioid manufacturer and marketer Johnson & Johnson.

Read the full story

Nearly 75 Percent of Pennsylvania Counties Have Signed Onto Opioid Settlement

The Center Square
pill bottles spilled onto a table

Fifty Pennsylvania counties have joined a historic global opioid settlement that is expected to bring $1 billion to the state to fight the opioid crisis.

The $26 billion settlement involves the nation’s three major pharmaceutical distributors – Cardinal, McKesson and AmerisourceBergen – as well as Johnson & Johnson. The agreement requires industry changes to help prevent a similar crisis in the future, in addition to the funds, Pennsylvania Attorney General Josh Shapiro said.

“Pennsylvania lost 5,172 lives to overdoses in the last year alone, which is 14 Pennsylvanians a day. This settlement is going to provide resources to jumpstart programs that will change lives and impact families across our commonwealth who are struggling to find treatment and help for those struggling with substance abuse,” Shapiro said. “These funds will be earmarked to offer and expand life-saving treatment options, prioritizing the areas that have been most affected by this crisis.”

Read the full story

Version of Pfizer Vaccine that Predates FDA Approval Still Being Distributed in Pennsylvania

Bradley Vasoli
healthcare worker giving vaccination

Of the three companies producing COVID vaccines in the U.S., only one—Pfizer Inc.—has yet gained full FDA approval, and at least some Pfizer vaccines currently being administered in Pennsylvania come from inventory that predates that approval.

On Aug. 23, the U.S. Food and Drug Administration (FDA) approved a Pfizer shot to prevent severe COVID-19 cases. Like Johnson & Johnson and Moderna, Pfizer had been a manufacturing vaccine to fight the coronavirus under federal emergency-use authorization (EUA). The injection produced by Pfizer under EUA is known as Pfizer BioNTech and the company’s post-FDA approval vaccine is called Comirnaty (pronounced kuh-MUR-nit-ee).

Read the full story

Project Veritas Catches Johnson & Johnson Employees Arguing Against Children Getting Vaccinated

Admin

Two Johnson & Johnson employees have admitted on hidden camera that children should not be forced to get injected with a COVID vaccine because of the potential of long-term side effects.

In Part 3 of Project Veritas’ COVID vaccine investigative series, a J&J scientist also voiced support for making unvaccinated Americans feel like second class citizens to coerce them into getting the jab, while at the same time recommending against getting the J&J COVID vaccine. “Don’t get the Johnson & Johnson,” Justin Durrant told a Project Veritas undercover journalist. “I didn’t tell you though,” he added.

Brandon Schadt, J&J’s Regional Business Lead, told the undercover journalist, “J&J is like stepping in the best smelling pile of sh-t you could step in.”

Read the full story

FDA Fully Approves Pfizer’s COVID Vaccine

The Center Square

The U.S. Food and Drug Administration gave full approval Monday to the Pfizer COVID-19 vaccine, a major step that will likely have significant implications for vaccination mandates nationwide. The Moderna and Johnson & Johnson vaccines have not yet received full FDA authorization.

The Pfizer vaccine previously received FDA authorization, which allowed its emergency use but did not give the full approval. Pfizer is the first company to receive full approval in the U.S.

Read the full story

Michigan Could Get $800 Million from Opioid Settlement

The Center Square

Michigan could receive up to nearly $800 million from a proposed multibillion-dollar national opioid settlement with Johnson & Johnson and the three largest pharmaceutical distributors in the country: Cardinal Health, McKesson, and AmerisourceBergen.

Michigan Attorney General Dana Nessel officially signed the agreement announced last month for the companies role in the opioid epidemic.

Read the full story

Factory Mixup Ruins 15 Million Johnson & Johnson Coronavirus Vaccines

Admin
COVID-19 Vaccinations

Workers at a Baltimore plant responsible for producing two separate coronavirus vaccines mistakenly mixed up their respective ingredients, ruining approximately 15 million doses of Johnson & Johnson’s vaccine and pausing all production at the plant, the company confirmed Wednesday.

The facility, run by Emergent BioSolutions, had partnered with both Johnson & Johnson and AstraZeneca to produce vaccines. Federal officials said that the mistake was a result of human error, according to The New York Times, which first reported the mix up that reportedly occurred several weeks ago.

A quality control review “identified one batch of drug substance that did not meet quality standards at Emergent BioSolutions, a site not yet authorized to manufacture drug substance for our COVID-19 vaccine,” Johnson & Johnson said in a statement. “This batch was never advanced to the filling and finishing stages of our manufacturing process.”

Read the full story

Johnson and Johnson Ships 4 Million Vaccine Doses, Shots Expected Within 48 Hours

Admin

Johnson & Johnson’s coronavirus vaccine began distribution across the country Monday, and the company’s CEO said shots could begin within 48 hours.

“We’re shipping 4 million [doses] literally as we speak,” Johnson & Johnson CEO Alex Gorsky told NBC News Monday morning. “Within the next 24 to 48 hours, Americans should start receiving shots in arms.”

Gorsky added that the company was on track to distribute 100 million shots by the end of June and 1 billion by the end of 2021. Johnson & Johnson’s vaccine was recommended by the FDA’s vaccine advisory panel on Friday and officially approved one day later.

Read the full story

FDA Panel Votes to Recommend Johnson & Johnson’s Coronavirus Vaccine for Emergency Authorization

Admin

The Food and Drug Administration’s vaccine advisory panel voted Friday evening to recommend Johnson & Johnson’s coronavirus vaccine for emergency approval, clearing the way for its authorization, distribution and administration nationwide.

The vote followed hours of the panel live-streaming its process of scouring over data from the pharmaceutical company in order to reaffirm that the vaccine was safe for the millions of Americans who will receive it. The FDA also released the vaccine’s clinical trial data on Wednesday showing that the vaccine was effective in fighting the virus itself.

Read the full story

Virginia Gov. Northam Relaxes More Outdoor COVID-19 Restrictions, Announces Vaccine Progress

Eric Burk

As warmer weather starts to tempt Virginians out of their COVID caves, Governor Ralph Northam announced another round of relaxed restrictions on outdoor activities, effective March 1. On Wednesday, Northam amended Executive Order 72 to allow up to 25 people at outdoor social gatherings, allows outdoor venues to have the lesser of either 1,000 people or 30 percent of their capacity, allows overnight summer camps to begin operations on May 1, and extends alcohol sales curfews until midnight, when restaurants must still close.

Read the full story

Johnson & Johnson’s Coronavirus Vaccine Offers Strong Protection, Reduces Spread, FDA Analysis Finds

Admin

Johnson & Johnson’s one-dose vaccine is effective in preventing severe and fatal coronavirus cases, and may reduce the virus’s transmission among vaccinated people, the FDA said in new analyses Wednesday.

The drug maker announced in January that its vaccine was 72% effective against the virus in the United States and 64% effective in South Africa, where a mutated, more transmissible strain has become dominant. Its vaccine was 86% effective in preventing severe virus cases in the U.S., meaning that a vaccinated individual is at a far smaller risk of being hospitalized or dying from COVID-19.

Read the full story

Johnson & Johnson Files for Emergency Authorization for Its Coronavirus Vaccine

Admin

Johnson & Johnson filed for emergency use authorization from the FDA on Thursday for its coronavirus vaccine.

The drug maker’s application followed its announcement that its vaccine was 72% effective in combating the virus. Although that’s slightly lower than Pfizer and Moderna’s vaccines, Johnson & Johnson’s requires one dose instead of two.

Read the full story

AstraZeneca, Johnson and Johnson Resuming U.S. Tests of COVID-19 Vaccines

The Associated Press

Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.

Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data.

Read the full story

Johnson & Johnson Begins Final Stage of Testing for Its Single-Dose COVID-19 Vaccine

Admin

Johnson & Johnson began its final round of testing for its COVID-19 vaccine Wednesday.

The study is one of the most expansive to occur so far, involving 60,000 volunteers across the United States, Argentina, Brazil, Chile, Peru, Mexico and South Africa, the Associated Press reported. The vaccine is the latest to begin its final testing phase, joining candidates developed by Moderna and Pfizer, and is the only vaccine that would be administered as a single dose.

Read the full story

Seven Pharma Execs Who Testified Before Congress Tuesday Make a Combined $116 Million Per Year

Admin

by Evie Fordham   Five of the seven pharmaceutical companies who sent executives to testify on drug pricing before the Senate Finance Committee Tuesday have the top-25 highest-paid pharma CEOs for companies in the S&P 500. CEOs from AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer and Sanofi plus Johnson & Johnson’s executive vice president of pharmaceuticals, Jennifer Taubert, were grilled by Senate Finance Chair Chuck Grassley and other lawmakers at the hearing. Altogether, the top-25 CEOs whose companies were represented Tuesday received a combined $116,671,792 in compensation, including stock and stock options, in 2017, according to analysis by The Wall Street Journal. That number includes annual compensation for former Pfizer CEO Ian Read, who ceded the position to new CEO Albert Bourla in January. Bourla testified before the committee Tuesday. Johnson & Johnson CEO Alex Gorsky rakes in the most out of the CEOs, with yearly compensation valued at $29,802,564, according to The WSJ. Taubert, who repped Johnson & Johnson and its pharmaceutical arm Janssen at Tuesday’s hearing, has no annual compensation data available according to Bloomberg. The runner-up is former Pfizer CEO Ian Read, who had yearly compensation of more than $27 million. He had agreed to delay implementing proposed…

Read the full story